drugsScienceWegovy Slashes the Risk of Heart Attack and Stroke in a Landmark TrialBy Emily MullinScienceThe FDA Approves Weight Loss Drug Zepbound, a Wegovy and Ozempic RivalBy Emily MullinScienceCalifornia Nixes a Bill to Decriminalize Plant-Based PsychedelicsBy Celia FordScienceCovid Boosters Can’t Outpace New Mutations. Here’s Why They Still WorkBy Emily MullinScienceOzempic and Wegovy Can Also Protect Your HeartBy Emily MullinCultureAdderall Shortages Are Dragging On—Can Video Games Help?By Celia FordScienceEveryone Was Wrong About AntipsychoticsBy Max G. LevyScienceThe First Pill for Postpartum Depression Is Almost HereBy Emily MullinScienceTicks and the Diseases They Carry Are Spreading. Can This Drug Stamp Them Out?By Maryn McKennaScienceThe US Finally Approved an Over-the-Counter Birth Control Pill. Here’s What to KnowBy Emily MullinSecuritySilk Road’s Second-in-Command Gets 20 Years in PrisonBy Andy GreenbergScienceThe One-Shot Drug That Keeps on DosingBy Max G. LevyScienceAbortion Pill Use Is Surging. Now It’s Under ThreatBy Emily Mullin and Kate KnibbsSciencePsychedelic Therapy Is Here. Just Don’t Call It TherapyBy Grace BrowneScienceWhat the Scientists Who Pioneered Weight-Loss Drugs Want You to KnowBy Matt ReynoldsScienceA Pill Version of Ozempic Is ComingBy Emily MullinIdeasTo Combat the Overdose Crisis, Expand Drug-Checking ProgramsBy Abdullah Shihipar and Alexandra CollinsIdeasScientists Gave People Psychedelics—and Then Erased Their MemoryBy Shayla LoveSecurityChinese Labs Are Selling Fentanyl Ingredients for Millions in CryptoBy Andy GreenbergScienceInside the Secretive Life-Extension ClinicBy Frank SwainScienceThe Supreme Court Preserves Abortion Pill Access—TemporarilyBy Emily MullinScienceThe Supreme Court Has Delayed Its Abortion Pill DecisionBy Emily MullinScienceThe US Supreme Court Restores Access to Abortion Pills—for NowBy Emily MullinScienceThe Abortion Pill Legal Standoff Endangers Access to All DrugsBy Emily Mullin and Maryn McKennaMore Stories
